CHRISTIE KELLAR: Open Payments
NPI 1184161457 · PICAYUNE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 19 payments from 8 companies in 2025. Trend: 2023 $201 · 2024 $466 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $167 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $166 |
| Novo Nordisk Inc | 4 | $84 |
| ABBVIE INC. | 2 | $33 |
| Amgen Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Exact Sciences Corporation | 1 | $20 |
| SANOFI-AVENTIS U.S. LLC | 1 | $16 |
Products named: CAPLYTA, ZEPBOUND, MOUNJARO, Wegovy, Ozempic, OTEZLA, BREZTRI, Cologuard Collection Kit.
Industry payments across MS — which companies pay providers there.
